These two Food and Drug Administration-approved drugs for cancer treatment may hold the key to reversing Alzheimer's disease ...

The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients died, the drug’s manufacturer halted dosing under pressure from the FDA.

A new study from the University of British Columbia (UBC) has found that high insulin levels—commonly seen in people with ...

Experts are calling for tailored strategies to enhance the diagnosis, treatment, and monitoring of older people with multiple ...

There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) ...

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

Mariam Eskander, MD, explores how food insecurity and geographic barriers hinder breast cancer trial participation, ...

A groundbreaking study has revealed that adults with a history of low back pain stayed pain-free for nearly twice as long when they walked regularly. This is the first research of its kind to ...

Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...